Freedom Day Solutions’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,174
Closed -$267K 97
2023
Q2
$267K Sell
4,174
-806
-16% -$54K 0.12% 89
2023
Q1
$333K Sell
4,980
-253
-5% -$17.8K 0.16% 83
2022
Q4
$377K Sell
5,233
-869
-14% -$65.5K 0.19% 84
2022
Q3
$434K Sell
6,102
-1,620
-21% -$118K 0.24% 85
2022
Q2
$595K Buy
7,722
+271
+4% +$20.6K 0.3% 81
2022
Q1
$544K Buy
+7,451
New +$500K 0.23% 87
2021
Q4
Sell
-3,936
Closed -$233K 121
2021
Q3
$233K Sell
3,936
-449
-10% -$29.6K 0.11% 109
2021
Q2
$293K Sell
4,385
-22,141
-83% -$1.44M 0.14% 104
2021
Q1
$1.68M Sell
26,526
-466
-2% -$29K 0.89% 55
2020
Q4
$1.67M Sell
26,992
-831
-3% -$51.1K 0.91% 54
2020
Q3
$1.68M Sell
27,823
-1,257
-4% -$75.7K 0.99% 51
2020
Q2
$1.71M Sell
29,080
-218
-0.7% -$13K 1.13% 46
2020
Q1
$1.63M Buy
29,298
+803
+3% +$49.1K 1.39% 30
2019
Q4
$1.83M Buy
+28,495
New +$1.63M 1.22% 38

Other funds holding BMY

Freedom Day Solutions's BMY Position: Q3 2023 in Review

Freedom Day Solutions sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 4,174 shares — an estimated $267K sold.

Freedom Day Solutions first reported a position in BMY in Q4 2019 and held it in 14 quarters. The position peaked at $1.83M in Q4 2019. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • Freedom Day Solutions reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • Freedom Day Solutions sold 4,174 Bristol-Myers Squibb shares in Q3 2023, an estimated $267K.
  • Freedom Day Solutions first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 14 quarters.
  • Freedom Day Solutions's Bristol-Myers Squibb position peaked at $1.83M in Q4 2019.
  • 2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Freedom Day Solutions's 13F filing for Q3 2023, filed 26 Oct 2023.